Haematologica
(Jun 2024)
De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine
- Roochi Trikha,
- Kar Lok Kong,
- James Galloway,
- Tanya N. Basu,
- Lynn Quek,
- Jamie Wilson,
- Louise Gamble,
- Henna Wong,
- Steven Best,
- Austin Kulasekararaj
Affiliations
- Roochi Trikha
- Haematology Department, King’s College Hospital NHS Foundation Trust, London
- Kar Lok Kong
- Synnovis, Laboratory for Molecular Haemato-Oncology, King’s College Hospital NHS Foundation Trust
- James Galloway
- Rheumatology Department, King’s College Hospital NHS Foundation Trust, London
- Tanya N. Basu
- Dermatology Department, King’s College Hospital NHS Foundation Trust, London
- Lynn Quek
- Haematology Department, King’s College Hospital NHS Foundation Trust, London, UK; King’s College London, London
- Jamie Wilson
- Department of Haematology, University Hospitals Sussex NHS Foundation Trust, Chichester
- Louise Gamble
- Clinical Haematology, Salisbury NHS Foundation Trust, Salisbury UK
- Henna Wong
- Department of Haematology, Hampshire Hospitals NHS Foundation Trust, Basingstoke
- Steven Best
- Synnovis, Laboratory for Molecular Haemato-Oncology, King’s College Hospital NHS Foundation Trust
- Austin Kulasekararaj
- Haematology Department, King’s College Hospital NHS Foundation Trust, London, UK; King’s College London, London
- DOI
-
https://doi.org/10.3324/haematol.2024.285519
- Journal volume & issue
-
Vol. 999,
no. 1
WeChat QR code
